Skip to main content
. 2023 Apr 24;12(9):3097. doi: 10.3390/jcm12093097

Figure 6.

Figure 6

OS and BCSS of chemotherapy-treated OBC patients after PSM adjustment (stratified by molecular subtype). (A) OS of HR+/HER2− subtype; (B) OS of HR+/HER2+ subtype; (C) OS of HR−/HER2+ subtype; (D) OS of HR−/HER2− subtype; (E) BCSS of HR+/HER2− subtype; (F) BCSS of HR+/HER2+ subtype; (G) BCSS of HR−/HER2+ subtype; (H) BCSS of HR−/HER2− subtype.